Latest Period
Q2 2026
Security Snapshot
Revolution Medicines, Inc. - Common Stock, par value $0.0001 per share (RVMD) Institutional Ownership
CUSIP: 76155X100
13F Institutional Holders and Ownership History from Q1 2020 to Q2 2026
Institutions Reporting
687
Shares (Excl. Options)
213,822,395
Price
$187.28
Save this security page for your next review
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.
- Security type / class
- Equity / Common Stock, par value $0.0001 per share
- Symbol
- RVMD on Nasdaq
- All holders as of 30 Jun 2026
- Q2 2026
- Total 13F shares
- 213,822,395
- Total 13F value
- $40,113,966,500
- Portfolio coverage rank
- 0.05%
- Share change
- +16,681,630
- Value change
- +$3,460,033,754
- Number of holders
- 687
- Shares outstanding
- 215,912,396
- SEC-reported price per share
- $180.92
- Insider filing price
- $180.92
Latest holder snapshot
5 signals
Issuer context
Names, identifiers, and filing context for this profile.
3 identity fields
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Key facts
- RVMD - Revolution Medicines, Inc. - Common Stock, par value $0.0001 per share is tracked under CUSIP 76155X100.
- 687 institutions reported positions in Q2 2026.
- 7 significant owners is listed from Schedule 13D/13G reporting.
Change
- Holder count moved from 508 to 687 between Q1 2026 and Q2 2026.
- SEC-reported value moved from $19,031,697,352 to $40,113,966,500.
Research use
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Evidence
Source: SEC Form 13F
Open SEC evidence
Latest holder context comes from 687 institutions filings for Q2 2026.
Security key
76155X100
Latest holder period
Q2 2026
13F holders
687
13D/G owners
7
CIK / CUSIP context first
Open Q2 2026 holders
RVMD full holder history
Revolution Medicines, Inc. SEC filings
Revolution Medicines, Inc. company facts
Revolution Medicines, Inc. insider transactions
Broader feeds
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 76155X100:
13D/G owners
Significant owners
Large-stake holder rows connected to Schedule 13D/G evidence.
Rows
7
Security
RVMD
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| Farallon Capital Partners, L.P. | 7.5% | -5% | $1,499,170,464 | +$137,025,822 | 14,596,149 | +10% | Dapice Joshua J. | 31 Dec 2025 |
| FARALLON CAPITAL MANAGEMENT, L.L.C. | 6.4% | $2,566,879,557 | 13,564,149 | Farallon Capital Management, L.L.C. | 30 Jun 2026 | |||
| BlackRock, Inc. | 5.7% | +24% | $2,285,077,256 | +$712,072,458 | 12,201,395 | +45% | BlackRock, Inc. | 30 Jun 2026 |
| BAKER BROS. ADVISORS LP | 5.3% | +8% | $2,165,540,879 | +$376,209,120 | 11,443,357 | +21% | Baker Bros. Advisors LP | 30 Jun 2026 |
| Janus Henderson Group Ltd. | 5.1% | +4% | $2,031,708,080 | +$183,496,377 | 10,736,145 | +9.9% | JANUS HENDERSON GROUP Ltd. | 30 Jun 2026 |
| FMR LLC | 5% | $439,058,769 | 9,401,687 | FMR LLC | 30 Sep 2025 | |||
| WELLINGTON MANAGEMENT GROUP LLP | 3.6% | -32% | $717,700,402 | -$336,077,288 | 6,987,639 | -32% | Wellington Management Group LLP | 31 Dec 2025 |
As of 30 Jun 2026, 687 institutional investors reported holding 213,822,395 shares of Revolution Medicines, Inc. - Common Stock, par value $0.0001 per share (RVMD). This represents 99% of the company’s total 215,912,396 outstanding shares.
13F concentration
Top 25 institutional shareholders
Largest 13F positions for this security by reported shares and value.
Top holder share
70%
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| BlackRock, Inc. | 6.3% | 13,695,790 | +22% | 0.04% | $2,564,947,573 |
| FARALLON CAPITAL MANAGEMENT, L.L.C. | 6.3% | 13,550,796 | -0.4% | 15% | $2,537,793,075 |
| FMR LLC | 5.7% | 12,200,422 | +44% | 0.1% | $2,284,894,993 |
| BAKER BROS. ADVISORS LP | 5.3% | 11,443,357 | +20% | 11% | $2,143,111,899 |
| Jupiter Topco LLC | 5% | 10,736,145 | 0% | 0.82% | $2,010,360,348 |
| Darwin Global Management, Ltd. | 4.9% | 10,629,822 | +381% | 54% | $2,047,516,314 |
| VANGUARD CAPITAL MANAGEMENT LLC | 4.2% | 9,088,661 | +8.7% | 0.04% | $1,702,124,432 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 3.8% | 8,294,855 | +11% | 0.07% | $1,553,460,444 |
| Nextech Invest Ltd. | 3.5% | 7,601,087 | 0% | 68% | $1,423,531,573 |
| Paradigm Biocapital Advisors LP | 2.9% | 6,361,323 | -4.4% | 22% | $1,191,348,571 |
| UBS Group AG | 2.5% | 5,448,364 | +24% | 0.16% | $1,020,369,610 |
| STATE STREET CORP | 2.3% | 4,897,051 | +11% | 0.03% | $917,119,711 |
| Capital World Investors | 1.9% | 4,008,244 | 0.09% | $750,663,936 | |
| GEODE CAPITAL MANAGEMENT, LLC | 1.8% | 3,942,676 | +18% | 0.04% | $736,814,054 |
| WELLINGTON MANAGEMENT GROUP LLP | 1.8% | 3,843,415 | -36% | 0.12% | $719,794,762 |
| JPMORGAN CHASE & CO | 1.5% | 3,298,066 | +994% | 0.04% | $636,932,609 |
| BVF INC/IL | 1.4% | 2,965,160 | +3.8% | 14% | $555,315,165 |
| Alphabet Inc. | 1.4% | 2,946,619 | -11% | 0.56% | $551,842,806 |
| Casdin Capital, LLC | 1.2% | 2,577,333 | 0% | 24% | $482,682,924 |
| DEERFIELD MANAGEMENT COMPANY, L.P. | 1.1% | 2,392,000 | +4.1% | 4.7% | $447,973,760 |
| PRICE T ROWE ASSOCIATES INC /MD/ | 1.1% | 2,390,303 | -26% | 0.04% | $447,657,000 |
| Avoro Capital Advisors LLC | 1.1% | 2,297,000 | -2% | 3.9% | $430,182,160 |
| NORGES BANK | 1% | 2,157,479 | 0.04% | $404,052,667 | |
| GOLDMAN SACHS GROUP INC | 0.99% | 2,133,101 | -2.4% | 0.04% | $399,487,223 |
| Nearwater Capital Markets, Ltd | 0.97% | 2,097,000 | +209% | 6.8% | $392,726,160 |
Quarter history
Institutional holders across reporting periods
Holder count, reported shares/value, and median price by quarter.
Periods
26
Latest
Q2 2026
Rows shown
1-25 of 26
| Period | 13F Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2026 Q2 | 213,822,395 | $40,113,966,500 | +$3,460,033,754 | $187.28 | 687 |
| 2026 Q1 | 195,862,090 | $19,031,697,352 | -$293,509,098 | $97.25 | 508 |
| 2025 Q4 | 199,291,575 | $15,874,883,737 | +$489,477,380 | $79.65 | 386 |
| 2025 Q3 | 191,767,706 | $8,955,119,353 | +$87,454,891 | $46.70 | 318 |
| 2025 Q2 | 190,726,235 | $7,017,009,498 | -$4,134,347 | $36.79 | 305 |
| 2025 Q1 | 191,051,347 | $6,776,444,446 | -$111,943,197 | $35.36 | 281 |
| 2024 Q4 | 193,048,484 | $8,445,124,761 | +$672,301,180 | $43.74 | 278 |
| 2024 Q3 | 170,577,261 | $7,735,337,873 | +$69,484,732 | $45.35 | 252 |
| 2024 Q2 | 168,410,110 | $6,536,274,916 | +$309,463,084 | $38.81 | 221 |
| 2024 Q1 | 160,549,965 | $5,174,502,235 | +$41,971,613 | $32.23 | 207 |
| 2023 Q4 | 159,991,814 | $4,588,662,174 | +$1,173,667,984 | $28.68 | 183 |
| 2023 Q3 | 112,410,338 | $3,111,480,815 | +$13,449,543 | $27.68 | 165 |
| 2023 Q2 | 111,960,439 | $2,994,417,481 | +$107,072,959 | $26.75 | 138 |
| 2023 Q1 | 108,245,336 | $2,343,498,970 | +$420,665,649 | $21.66 | 149 |
| 2022 Q4 | 88,251,337 | $2,102,174,977 | +$32,658,345 | $23.82 | 133 |
| 2022 Q3 | 88,392,782 | $1,743,047,001 | +$233,806,685 | $19.72 | 133 |
| 2022 Q2 | 76,461,750 | $1,490,187,152 | +$40,971,035 | $19.49 | 125 |
| 2022 Q1 | 73,955,592 | $1,885,584,241 | +$15,751,102 | $25.51 | 122 |
| 2021 Q4 | 73,332,089 | $1,845,795,329 | -$50,104,402 | $25.17 | 113 |
| 2021 Q3 | 68,952,735 | $1,896,915,710 | +$49,809,012 | $27.51 | 109 |
| 2021 Q2 | 70,364,140 | $2,233,248,707 | +$91,598,352 | $31.74 | 127 |
| 2021 Q1 | 66,456,882 | $3,048,913,145 | +$424,322,383 | $45.88 | 124 |
| 2020 Q4 | 57,426,011 | $2,273,517,142 | +$133,648,027 | $39.59 | 118 |
| 2020 Q3 | 56,953,834 | $1,981,075,717 | +$339,721,674 | $34.80 | 90 |
| 2020 Q2 | 46,886,789 | $1,478,128,925 | +$22,763,370 | $31.57 | 73 |